The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.
Dellann Elliott Mydland
Advertisement
Articles by Dellann Elliott Mydland
An easier application process could make experimental drugs more accessible to patients in need — outside the realm of clinical trials.
Dellann Elliott Mydland, founder and president of the EndBrainCancer Initiative and 2016 GBM Hero, discusses how miracles do happen in the world of glioblastoma multiforme (GBM), and people survive.
Could immediate access to care be the turning point?
Dellann Elliott Mydland, from the Chris Elliott Fund, discusses testing brain tumor tissue before surgery.
2015 started off with a bang, with a focus on brain cancer patients and new treatment options for recurrent glioblastoma (rGBM).
Advertisement
Latest Updated Articles
Miracles Do Happen in GBMPublished: January 5th 2017 | Updated:
Clinical Trial Opportunity for Patients With Recurrent GlioblastomaPublished: May 28th 2015 | Updated:
Dellann Elliott Mydland on Testing Brain Tumor TissuePublished: June 17th 2015 | Updated:
- Expanding Expanded Access
Published: December 18th 2017 | Updated:
- Having a Say in Shaping Brain Cancer Treatment
Published: May 13th 2020 | Updated:
- Effecting Change in Glioblastoma
Published: August 21st 2015 | Updated:
Advertisement
Advertisement
